In this context, our observation that E2 attenuates ECM overproduction—potentially through modulation of the TGF-β/Smad signaling cascade—suggests a novel therapeutic approach for addressing this key pathogenic mechanism in FECD. Here, TGFB1 is linked to Fuchs endothelial corneal dystrophy.